BeStock  
Stocks › Biotechnology › SNDX

Syndax Pharmaceuticals SNDX

US equityMarket cap rank #3319Biotechnology
$8.72 −$0.41 (-4.49%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.72 0.00%
Open$9.07
Prev close$9.13
Day range$8.69 – $9.27
Volume2.18M
Market cap$785.05M
P/E (TTM)–
Dividend yield–

SNDX Stock News

Headlines matching Syndax Pharmaceuticals or the SNDX ticker, most recent first.

  • Citi Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $57Market news · 29 Sep 2026 · Direct mention
  • H.C. Wainwright Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX)TipRanks · 22 Sep 2026 · Direct mention
  • Syndax Pharmaceuticals | SCHEDULE 13G: OthersSEC · 7 Aug 2026 · Related
  • A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $26 to $57Market news · 5 Aug 2026 · Direct mention
  • 10-Q: Syndax Pharmaceuticals | 10-Q: Q2 2026 Earnings ReportSEC · 5 Aug 2026 · Related
  • 8-K: Syndax Pharmaceuticals | 8-K: Syndax Reports Second Quarter 2026 Financial Results and Provides Business UpdateSEC · 5 Aug 2026 · Related
  • BofA Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $26 NegativeMarket news · 5 Aug 2026 · Direct mention
  • UBS Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $33 NegativeMarket news · 21 Aug 2026 · Direct mention
  • Stifel Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $40Market news · 14 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $40 NegativeMarket news · 11 Aug 2026 · Direct mention
  • BofA Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $29Market news · 22 Jul 2026 · Direct mention
  • Barclays Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $37Market news · 20 Jul 2026 · Direct mention
  • TD Cowen Maintains Syndax Pharmaceuticals(SNDX.US) With Buy RatingMarket news · 16 Jul 2026 · Direct mention
  • Goldman Sachs Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $34Market news · 15 Jul 2026 · Direct mention
  • Stifel Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $46Market news · 15 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on SNDX.

Sign in to join the discussion.

Scroll to Top